Literature DB >> 12028627

Laparoscopic partial adrenalectomy for recurrent pheochromocytoma after open partial adrenalectomy in von Hippel-Lindau disease.

Saif Al-Sobhi1, Reinhard Peschel, Christine Zihak, Georg Bartsch, Hartmut Neumann, Günter Janetschek.   

Abstract

BACKGROUND AND
PURPOSE: Unilateral total adrenalectomy is the standard treatment for benign unilateral adrenal tumors. Partial adrenalectomy has to be considered for bilateral adrenal tumors. Recently, our group has reported the feasibility of unilateral and bilateral partial adrenalectomy by means of laparoscopy. Now, we present a case of recurrent pheochromocytoma after open bilateral adrenalectomy and demonstrate that laparoscopic cortex-sparing surgery is feasible for a recurrence after open surgery. CASE REPORT: At the age of 10 years, a boy was found to have bilateral adrenal pheochromocytoma and was treated by open bilateral partial adrenalectomy. Eight years later, the patient presented with palpitation, sweating, and severe hypertension. Investigations biochemically and radiologically demonstrated functional recurrent pheochromocytoma in the left adrenal gland. Genetic studies confirmed mutation of the von Hippel-Lindau (VHL) gene. The patient was prepared for surgery preoperatively by phenoxybenzamine and metropolol. The surgery was performed as planned, and the normal adrenal tissue was spared. The patient had an uneventful postoperative course. His blood pressure was normal on the day of discharge.
CONCLUSIONS: In a specialized center with experienced laparoscopic surgeons, laparoscopic partial adrenalectomy for recurrent pheochromocytoma is feasible even after previous open surgery on the ipsilateral adrenal gland. Adrenal-sparing surgery is indicated in hereditary syndromes such as VHL and MEN II to avoid the problems of life-long steroid replacement. Recurrences have to be expected, but further surgery may be less difficult by the previous laparoscopic approach.

Entities:  

Mesh:

Year:  2002        PMID: 12028627     DOI: 10.1089/089277902753716142

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  8 in total

Review 1.  Adrenal-preserving minimally invasive surgery: update on the current status of laparoscopic partial adrenalectomy.

Authors:  Grant I S Disick; Ravi Munver
Journal:  Curr Urol Rep       Date:  2008-01       Impact factor: 3.092

Review 2.  Management of Adrenal Masses.

Authors:  Hattangadi Sanjay Bhat; Balagopal Nair Tiyadath
Journal:  Indian J Surg Oncol       Date:  2016-12-17

3.  Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome.

Authors:  Dmitry Volkin; Nitin Yerram; Faisal Ahmed; Dawud Lankford; Angelo Baccala; Gopal N Gupta; Anthony Hoang; Jeffrey Nix; Adam R Metwalli; David M Lang; Gennady Bratslavsky; W Marston Linehan; Peter A Pinto
Journal:  J Pediatr Surg       Date:  2012-11       Impact factor: 2.545

Review 4.  [Recurrent operations on the adrenal glands].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

5.  Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup.

Authors:  Jihane N Benhammou; Ronald S Boris; Karel Pacak; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-09-17       Impact factor: 7.450

6.  Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique.

Authors:  Kevin P Asher; Gopal N Gupta; Ronald S Boris; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  Eur Urol       Date:  2011-04-09       Impact factor: 20.096

Review 7.  Adrenal-preserving minimally invasive surgery: the role of laparoscopic partial adrenalectomy, cryosurgery, and radiofrequency ablation of the adrenal gland.

Authors:  Ravi Munver; Joseph J Del Pizzo; R Ernest Sosa
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

8.  Pheochromocytoma.

Authors:  Lee C Pederson; Jeffrey E Lee
Journal:  Curr Treat Options Oncol       Date:  2003-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.